Stakeholders ask for more details in FDA’s IT, customer service strategies
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)User feesRegulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)User fees